Magnolia NeuroSciences (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- August 13, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $31,000,000
Company Info
- Founding Year
- 2018
- Founders
- Thong Q. Le
- Company Description
- Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.
- Market
- CNS diseases
- Location
- New York, New York, United States
- Coinvestors
- 180 Degree Capital, AbbVie Biotech Ventures, Alexandria Real Estate Equities, ARCH Venture Partners, Eli Lilly and Company, Innovate NY Fund, Johnson & Johnson Development Corporation (JJDC), Partnership Fund for New York City, Pfizer Strategic Investments Group, Watson Fund, WuXi Corporate Venture Fund